Globe Life Earnings Call Signals Durable Growth Path

Globe Life Inc. ((GL)) has held its Q1 earnings call. Read on for the main highlights of the call.

Globe Life Inc. struck an upbeat tone on its latest earnings call, pairing double‑digit operating EPS growth with strong health sales and disciplined capital returns. Management acknowledged pockets of pressure in lapses, agent retention, and expenses, but argued these are manageable and outweighed by rising investment yields, a stronger balance sheet, and enhanced shareholder payouts.

Robust Earnings and EPS Momentum

Globe Life reported Q1 2026 net income of $271 million, or $3.39 per share, up from $255 million or $3.01 a year ago. Net operating income per share climbed 12% to $3.43 from $3.07, underscoring solid underlying performance rather than one‑off gains.

Book Value Growth and Attractive Returns

The insurer posted a GAAP return on equity of 17.9% through March 31, with book value per share at $77.30. Excluding AOCI, ROE was 14% and book value rose to $98.56, a 12% year‑over‑year increase that highlights ongoing value creation despite rate‑driven market volatility.

Premium Expansion and Healthy Underwriting Margins

Total premium revenue rose 6% in Q1, and the company expects around 7% growth for the full year. Life premiums increased 3% to $853 million with a 41% margin, while health premiums surged 13% to $417 million and delivered a roughly 23% underwriting margin.

Health Sales Surge and Solid Life Production

Sales momentum was particularly strong in health, where net sales jumped 58% in the quarter. Overall life net sales grew 6%, driven by divisions like United American General Agency and Family Heritage, which posted sizeable gains in supplemental health business.

Distribution Strength and Agency Growth

American Income grew life premiums 5% to $459 million and boosted underwriting margin 7% to $209 million. Liberty National and Family Heritage both expanded average producing agent counts and health premiums, signaling durable growth in core agency distribution channels.

Investment Portfolio and Yield Tailwinds

Globe Life managed $22 billion of invested assets, including $19.1 billion in fixed maturities, with a Q1 earned yield of 5.5%. New fixed‑maturity purchases came in at a 6.23% yield, and management expects a full‑year long‑term yield between 5.45% and 5.50% as reinvestment benefits build.

Capital Returns and Liquidity Management

The company returned about $225 million to shareholders in Q1, including $205 million of buybacks for roughly 1.4 million shares and about $20 million in dividends. Management lifted the annual dividend by 22% and raised the 2026 repurchase target to a range of $560 million to $610 million.

Solid Capital and Solvency Position

Globe Life’s U.S. insurance subsidiaries ended 2025 with a consolidated RBC ratio of 316%, above the firm’s 300% minimum target. That level implies around $95 million of excess capital and sits comfortably within the company’s desired 300% to 320% range.

Guidance Upgrade and Remeasurement Tailwind

For 2026, management guided net operating EPS to $15.40–$15.90, implying roughly 8% growth at the midpoint and about 11% normalized growth excluding assumption updates. The outlook includes a sizable Q3 remeasurement benefit of $70 million to $110 million pre‑tax, which is expected to lift that quarter’s life margin into the 49%–54% range.

Incremental Investment Income Supports Earnings

Net investment income climbed 3% year‑over‑year to $290 million, with excess investment income up about $1 million to $37 million. For the full year, both net investment income and required interest are projected to grow around 4%, implying excess investment income growth in the 4%–4.5% band.

Agent Count and Retention Headwinds at American Income

Despite strong financials, American Income’s average producing agent count slipped 4% to 11,064 as new agent retention weakened and first‑year lapses increased. Management is tweaking middle‑management compensation to prioritize recruiting and retention, aiming to stabilize the sales force over time.

Elevated Lapses and Persistency Risk

Executives warned that lapse rates are likely to stay above pre‑pandemic levels through 2026, particularly at American Income where Q1 experience worsened. Higher lapses can pressure renewal premiums and agent morale, creating a near‑term drag even as the broader franchise continues to grow.

Administrative Expense Pressure and Efficiency Plans

Administrative expenses rose about 8% to $94 million and reached 7.4% of premium in Q1, slightly above the 7.3% full‑year target. Management sees near‑term pressure but is investing in AI and technology to gradually push the admin‑to‑premium ratio closer to 7% over time.

Health Margin Seasonality and Claims Volatility

Health policy obligations increased to 56.3% of premium from 55.6% a year ago, reflecting typical Q1 claims seasonality at United American. While the segment delivered a 23% underwriting margin, the company maintained a wide full‑year range of 23%–27%, signaling expected quarter‑to‑quarter variability.

Unrealized Losses in Long‑Duration Bonds

The fixed‑maturity portfolio carried about $1.6 billion in unrealized losses, largely tied to higher market rates on bonds with maturities beyond 10 years. Management emphasized its intent and capacity to hold these securities to maturity, framing the losses as accounting marks rather than credit issues.

DTC Softness and Competitive Dynamics

Direct‑to‑consumer life premiums slipped about 1% to $244 million in Q1 amid tougher competition and new entrants leaning on AI‑driven models. Globe Life noted that its agency‑based channels remain more insulated, but the DTC slowdown highlights evolving competitive risks in digital distribution.

Forward Guidance Points to Sustained Growth

Looking ahead, Globe Life expects about 7% total premium growth in 2026, with life premiums up 3%–3.5% and health premiums up 14%–17%. Management is targeting life underwriting margins of roughly 42%–45% for the year, health margins of 23%–27%, a long‑term investment yield around 5.45%–5.5%, and continued capital returns via roughly $90 million of dividends and up to $610 million of share repurchases.

Globe Life’s call painted a picture of a steady compounder balancing growth, capital return, and risk management. While higher lapses, softer DTC premiums, and expense drift bear watching, the company’s rising earnings base, robust health sales, and strong capital position left management confident in its ability to deliver double‑digit normalized EPS growth over the next several years.